Trident Lifeline Ltd Directors Report

To,

The Members,

Trident Lifeline Limited

Your directors are pleased to present the 13^th Annual Report along with the Audited Standalone and
Consolidated Financial Statements and Auditors Report thereon of Trident Lifeline Limited (Trident Lifeline
or Company) for the Financial Year ended March 31, 2026.

1. FINANCIAL PERFORMANCE:

The Audited Financial Statements of your Company as on March 31, 2026, are prepared in accordance
with the Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("SEBI Listing Regulations") and the provisions of the Companies Act,
2013 ("Act").

The summarized financial highlights are depicted below:

(Amount in Lakhs)

Type of Borrower	STANDALONE		CONSOLIDATED
	2025-26	2024-25	2025-26	2024-25
Total Income	10607.05	7094.00	13829.28	9519.58
Total Expenditure other than Financial Costs and Depreciation	7756.95	5027.72	10091.35	7210.33
Profit before Financial cost, Depreciation and Exceptional items & Tax (EBITDA)	2850.1	2066.28	3737.93	2309.25
Finance Costs	166.25	122.83	412.02	398.52
Depreciation	185.93	152.87	606.64	549.25
Profit/(Loss) before Exceptional and Extraordinary items	2497.92	1790.58	2719.28	1361.49
Profit/(Loss) before Tax	2497.92	1790.58	2719.28	1361.49
Profit/(Loss) after Tax	1809.27	1305.14	1931.88	1049.48
Net Profit attributable to	1809.27	1305.14	1904.14	1174.79
- Owners of the Company	-	-	-	-
- Minority Interest	-	-	27.74	-125.31
Total Comprehensive Income attributable to-	1809.27	1305.14	1904.14	1174.79
- Owners of the Company	-	-	-	-
- Minority Interest	-	-	27.74	-125.31
Earnings per share (Basic & Diluted) (in )	15.37	11.35	16.32	10.22

2. FINANCIAL HIGHLIGHTS & OPERATIONS:

The Key highlights pertaining to the business of
the company for the year 2025-26 and period
subsequent there to have been given hereunder.

-Standalone

Your Directors inform you that, during the year under
review, Your Company has revenue from operations
of Rs.10607.05 Lacs and EBITDA of Rs.2850.1 Lacs
as against Rs.7094.00 Lacs and Rs.2066.28 Lacs
respectively in the previous year. During the year
under review the Company has earned net profit
after tax amounting to Rs.1809.27 Lacs as against
Rs.1305.14 Lacs in the previous year. The Companys

earnings per share were Rs.15.37 during the current
year. Your Directors are hopeful to achieve better
financial performance in the coming years.

-Consolidated

The consolidated total revenue of your Company for
FY 2025-26 stood at Rs.13829.28 Lacs and EBITDA
of Rs.3737.93 Lacs as against Rs.9519.58 Lacs and
Rs.2309.25 Lacs respectively in the previous year.
During the year under review the Company has
earned net profit after tax amounting to Rs.1931.88
Lacs as against Rs.1049.48Lacs in the previous year.
The Companys earnings per share were Rs.16.32
during the current year.

A detailed discussion on financial and operational
performance of the Company is given under
"Management Discussion and Analysis Report"
forming part of this Annual Report.

3. CHANGE IN THE NATURE OF THE
BUSINESS:

During the year, there was no change in the nature
of Business of the Company.

4. CHANGE IN SHARE CAPITAL:

During the financial year under review, the
Authorised Share Capital of the Company increased
from Rs.12,00,00,000 (Rupees Twelve Crore Only) to
Rs.15,00,00,000 (Rupees Fifteen Crore Only). Further,
the Paid-up Share Capital of the Company increased
from Rs.11,49,92,000 to Rs.11,93,30,000 pursuant to
the conversion of warrants into equity shares.

The equity shares of the Company are listed and
traded on BSE Limited under Scrip Code 543616.

5. STATEMENT OF DEVIATION(S)

OR VARIATION(S) IN ACCORDANCE

WITH REGULATION 32 OF SEBI (LODR)
REGULATIONS, 2015:

FOR IPO UTILIZATION:

In accordance with the offer document of the Initial
Public Offer, the Company had estimated utilization
of Rs.2050 Lacs towards Funding Working Capital
requirements of the Company, Rs.513.66 Lacs towards
Product registration in international markets,
Rs.670.53 Lacs towards General Corporate Purposes
and Rs.300 Lacs towards public issue expenses.

The actual utilization as on 31^st March, 2026 was
Rs.2035.65 Lacs towards Funding Working Capital
requirements of the Company, Rs.75.81 Lacs towards
Product registration in international markets,
Rs.670.49 Lacs towards General Corporate Purposes
and Rs.300.00 Lacs towards public issue expenses.
Remaining unutilized amount lying with the bank.

FOR PREFERENTILA ISSUE:

In accordance with the offer document of the
Preferential issue of warrants, the Company had
estimated utilization of Rs.2657.34 Lacs towards
of Meet working capital requirements, to make
investment in Subsidiary/associates/Joint Ventures
and to meet their working capital requirement,
repayment of Secured Borrowing of the Company,
Business Expansion and other general corporate
purpose.

The actual utilization as on 31^st March, 2026 was
Rs.1526.57 Lacs towards as mentioned in the offer
documents.

6. PUBLIC DEPOSITS:

Your Company has not accepted or renewed any
Public Deposits within the meaning of Section 73

and 74 of the Act read with rules made thereunder at
the end of the FY 2025-26 or the previous financial
years.

7. APPROPRIATIONS:

-Dividend:

The Board of directors does not recommend a
dividend for the year under review.

-Transfer to Reserve:

The Board of Directors have not proposed to transfer
any amount to any Reserve. Therefore, entire profits
of Rs.1809.27 Lakhs earned during the financial year
2025-26 have been retained in the profit and loss
account.

-Bonus Shares:

During the year the Company has not allotted any
Bonus Shares to its members.

8. RIGHT ISSUE:

During the year the Company has not issued any
Right shares to its members.

9. DEPOSITORY SYSTEM:

As members are aware, the companys shares are
compulsorily tradable in the electronic form. As on
March 31, 2026, 100% of the Companys total paid-
up capital representing 1,19,33,000 shares were in
dematerialized form. The ISIN of the Equity Shares of
your Company is INE0MKA01014.

10. CREDIT RATING:

The Company has not obtained Credit Rating from
any Credit Rating Agency as on the date of this
Report.

11. DETAILS OF LOANS/INVESTMENTS/
GUARANTEES:

The Companies has provided loans/guarantees to
its subsidiaries, associates and other parties and has
made investments during the year in compliance
with provisions of the Companies Act, 2013 and
rules made thereunder. The details of such loans/
guarantees provided as on March 31, 2026 are
provided in Note No. 11, 13, 19 and 30 of the
Standalone Financial Statements.

12. DISCLOSURES RELATING TO
SUBSIDIARIES, ASSOCIATES AND JOINT
VENTURES:

At the beginning of the year, the Company had Five
Subsidiary Companies-TNS Pharma Private Limited,
Trident Mediquip Limited, TLL Parenterals Limited
TLL Wellness Limited (Formally Knowns as TLL
Herbal Limited) and TLL Elements Private Limited
and during the year under review:

Except above, no other company has become or
ceased to be subsidiary, joint venture or associate
company during the year under review.

13. SUBSIDIARY COMPANIES AND ITS
FINANCIAL PERFORMANCE:

During the year under review, the Company had
five (5) subsidiaries viz. TNS Pharma Private Limited,
Trident Mediquip Limited, TLL Parenterals Limited
TLL Wellness Limited (Formally Knowns as TLL
Herbal Limited) and TLL Elements Private Limited.

Pursuant to the provisions of Section 129, 134 and
136 of the Act read with rules made thereunder

and Regulation 33 of the SEBI Listing Regulations,
the Company has prepared consolidated financial
statements and a separate statement containing the
salient features of financial statement of subsidiaries
in Form AOC-1 as Annexure-F, which forms part of
this Annual Report.

The Annual Financial Statements and related
detailed information of the subsidiary companies
shall be made available to the shareholders of the
holding and subsidiary companies seeking such
information on all working days during business
hours.

14. BOARD OF DIRECTORS:

As on March 31, 2026, your Companys Board had 6 members comprising 4 Executive Directors and 2 Non-
Executive & Independent Directors. The Board have 2 women Directors out of total directors as under:

Sr. No.	Name of Director	DIN	Designation
1	Hardik Jigishkumar Desai	01358227	Executive Director & Chairman
2	Shravan H Patel	08543127	Whole Time Director
3	Rupaben Chetan Jariwala	08629141	Managing Director
4	Ashish Anandsingh Bafna	01796556	Executive Director
5	Mishal Shailesh Patel	10584711	Independent Director
6	Falguni Bhavesh Jariwala	10250091	Independent Director

The Directors of your Company are well experienced having expertise in their respective fields of technical,
finance, strategic and operational management and administration.

During the year following changes in directorship were made:

-Appointed Mr. Ashish Anandsingh Bafna (DIN: 01796556), as Director of the Company.

-Appointed a Director in place of Mrs. Maniya Hardik Desai (DIN: 05351685), who retires by rotation and
being eligible offers, herself for re-appointment.

-Resignation of Mrs. Maniya Hardik Desai (DIN: 05351685) from the post of non-executive Director of the
Company.

None of the Directors of your Company are disqualified under the provisions of Section 164(2)(a) and (b) of the
Act.

In the opinion of the Board, the Independent Directors appointed during the year possess requisite integrity,
expertise, experience and proficiency.

The composition of Board complies with the requirements of the Companies Act, 2013. Further, in pursuance
of Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing
Regulations"), the Company is exempted from requirement of having composition of Board as per Listing
Regulations.

15. KEY MANAGERIAL PERSONNEL:

Pursuant to the provisions of section 203 of the Companies Act, 2013 read with rules framed thereunder the
following persons are the key Managerial Personnel of the company as on March 31, 2026:

1) Mr. Shravan H Patel, Managing Director.

2) Mrs. Rupaben Chetan Jariwala, Whole Time Director.

3) Mr. Ashish Anandsingh Bafna, Chief Financial Officer

4) Mrs. Nikita Sharma, Company Secretary and Compliance Officer.

16. DISCLOSURE RELATED TO BOARD, COMMITTEES AND POLICIES:

1. Board Meetings:

The Board of Directors met 13 times during the financial year ended March 31, 2026 in accordance with the
provisions of the Companies Act, 2013 and rules made there under as under:

Sr. No. Date on which Board Meetings were held	Total Strength of the Board	No. of Directors present
1. 16.04.2025	6	6
2. 28.04.2025	6	6
3. 19.05.2025	6	6
4. 09.06.2025	6	6
5. 01.07.2025	6	6
6. 28.07.2025	6	6
7. 01.09.2025	6	6
8. 11.11.2025	7	7
9. 21.11.2025	7	7
10. 05.12.2025	6	6
11. 16.12.2025	6	6
12. 27.12.2025	6	6
13. 17.01.2026	6	6
Attendance of Directors at Board Meetings
Name of the Directors	No. of Board meetings held	No. of Board Meetings attended
Mr. Hardik J. Desai	13	13
Mr. Shravan H Patel	13	13
Mrs. Rupaben Chetan Jariwala	13	13
Mr. Ashish Anandsingh Bafna	06	06
Mr. Mishal Shailesh Patel	13	13
Mrs. Falguni Bhavesh Jariwala	13	13

2. Committee Meetings:

Audit Committee

As on March 31, 2026, the Audit Committee of the Board comprises of three members viz; Mr. Mishal Shailesh
Patel (Independent and Non- Executive Director)-Chairman, Mrs. Falguni Bhavesh Jariwala (Independent and
Non- Executive Director)- Member and Mrs. Rupaben Chetan Jariwala (Whole Time Director)- Member.

All recommendations made by the Audit Committee were accepted by the Board during the year 2025-
2026. The Audit Committee met 05 times during the Financial Year ended March 31, 2026 as mentioned
below:

Sr. No. Date on which Audit Committee Meetings were held	Total Strength of Committee	Number of Member Present
1. 16.04.2025	3	3
2. 28.04.2025	3	3
3. 28.07.2025	3	3
4. 11.11.2025	3	3
5. 17.01.2026	3	3

2014, hence no information as required under the
provisions of Section 197 of the Companies Act,
2013 read with rule 5(2) and 5(3) of the Companies
(Appointment and Remuneration of Managerial
Personnel) Rules, 2014 are provided in this report.

In accordance with Section 178 of the Companies Act,
2013 and Regulation 19 of the Listing Regulations,
the Nomination and Remuneration Committee of
the Board of Directors approved the Nomination
and Remuneration Policy, which is available on the
website of the Company www.tridentlifeline.com.

21. DIRECTORSRs.RESPONSIBILITY
STATEMENT:

Pursuant to the requirement under Section 134(3)

(c) read with 134(5) of the Act, your Directors confirm
that:

(a) The applicable accounting standards have been
followed along with proper explanation relating
to material departures, if any, in the preparation
of the annual accounts;

(b) Appropriate accounting policies have been
selected and applied consistently and
judgments and estimates have been made
that are reasonable and prudent so as to give
a true and fair view of the state of affairs of the
Company at the end of the financial year and of
the profit of the Company for that period;

(c) Proper and sufficient care has been taken for the
maintenance of adequate accounting records
in accordance with the provisions of this Act for
safeguarding the assets of the Company and
for preventing and detecting fraud and other
irregularities;

(d) The annual accounts have been prepared on a
going concern basis;

(e) Proper internal financial controls have been laid
down and followed by the Company and that
such internal financial controls are adequate
and were operating effectively; and

(f) Proper systems to ensure compliance with the
provisions of all the applicable laws have been
devised and that such systems were adequate
and are working effectively.

Based on the framework of internal financial
controls and compliance systems established and
maintained by the Company, the work performed by
the internal, statutory and secretarial auditors and
external consultants, including the audit of internal
financial controls over financial reporting by the
statutory auditors and reviews performed by the
management and relevant Board Committee, the
Board is of the opinion that the Companys internal
financial controls were adequate and effective
during the financial year 2025-2026.

22. CORPORATE GOVERNANCE:

Pursuant to the provisions ofRegulation 15 of the SEBI
(Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("Listing Regulations"), the
Company is exempted from Reporting on Corporate
Governance and therefore the Company is not filing
Corporate Governance Report to the Stock Exchange
and hence the Report is not attached with this
Report. However, the Company is complying with
the provision of filing Corporate Governance Non-
Applicability Certificate to the Exchange.

Report on Corporate Governance Practices and the
Certificate regarding compliance of conditions of
Corporate Governance and certification by CEO/
Whole time Director & CFO is not applicable to
your Company as per regulation 15(2)(b) of SEBI
(Listing Obligation and Disclosure Requirements)
Regulations, 2015.

23. CORPORATE SOCIAL RESPONSIBILITY
POLICY:

At present, amount to be spent by a company under
sub-section (5) of Section 135 of the Companies act,
2013 does not exceed fifty lakh rupees, therefore the
requirement under sub-section (1) of section 135
of the Companies act, 2013 for constitution of the
Corporate Social Responsibility Committee shall not
be applicable and the functions of such Committee
provided under this section shall be discharged by
the Board of Directors of company.

This CSR Policy has been approved by the Board of
directors of the Company dated 6^th May, 2023 ("the
Board").

The CSR policy, covering the Objectives, Focus Areas,
Governance Structure Monitoring and Reporting
Framework among others is approved by the Board
of Directors. The CSR Policy is available on the
website of the Company and can be accessed at
www.tridentlifeline.com.

The main objective of Trident Lifelines CSR policy is
to make CSR a key business process for sustainable
development of society. In its endeavors to mutually
achieve the said objective, the Act stipulates the
provisions regarding mandatory adherence to the
Corporate Social Responsibility practices by the
prescribed classes of companies.

The Company has spent more than 2% of the
average net profits of the Company during the three
immediately preceding Financial Years on CSR.

The Annual Report on CSR activities, in terms of
Section 135 of the Companies Act, 2013 and the
Rules framed thereunder, is annexed to this Report
(Annexure B).

24. VIGIL MECHANISM/WHISTLE BLOWER
POLICY:

The company has a Whistle about the unethical
behavior, fraud or violation of Companys code of
conduct. Blower Policy for the vigil mechanism
of Directors and employees to report to the
management the mechanism provides for adequate
safeguards against victimization of employees and
Directors who use such mechanism and makes
provision for direct access to the chairman of the
Audit Committee in exceptional cases. None of the
personnel of the Company have been denied access
to the Audit Committee. The Whistle Blower Policy
is displayed on the Companys website viz. www.
tridentlifeline.com.

25. PREVENTION OF INSIDER TRADING:

The Company has adopted an Internal Code of
Conduct for Regulating, Monitoring and Reporting
of Trades by Insiders ("the Code") in accordance with
the SEBI (Prohibition of Insider Trading) Regulations,
2015(The PIT Regulations). The Code is applicable
to Promoters and Promoters Group, all Directors
and such Designated Employees who are expected
to have access to unpublished price sensitive
information relating to the Company. The Company
Secretary is the Compliance Officer for monitoring
adherence to the said PIT Regulations.

The Company has also formulated The Code of
Practices and Procedures for Fair Disclosure of
Unpublished Price Sensitive Information (UPSI)Rs.in
compliance with the PIT Regulations. This Code
is displayed on the Companys website viz. www.
tridentlifeline.com.

26. CODE OF CONDUCT:

The Company has adopted Code of Business
Conduct & Ethics ("the Code") which is applicable
to the Board of Directors, Senior Management,
Key Managerial Personnel, Functional heads and
all professionals serving in the roles of finance, tax,
accounting, purchase and investor relations of the
Company. The Board of Directors and the members
of the Senior Management Team (one level below the
Board of Directors) of the Company are required to
affirm annual Compliance of this Code. A declaration
signed by the Chairman and Managing Director
of the Company to this effect is placed at the end
of this report as Annexure-C. The Code requires
Directors and Employees to act honestly, fairly,
ethically and with integrity, conduct themselves in
a professional, courteous and respectful manner.
The Code is displayed on the Companys website viz.
www.tridentlifeline.com.

27. PREVENTION OF SEXUAL HARASSMENT
AT THE WORKPLACE:

The Company is conscious of the importance of
environmentally clean and safe operations. The
Companys policy requires conduct of operations in
such a manner so as to ensure safety of all concerned,
compliances of environmental regulations and
preservation of natural resources. As required by
the Sexual Harassment of Women at Workplace

(Prevention, Prohibition & Redressal) Act, 2013, the
Company has formulated and implemented a policy
on prevention of sexual harassment at the workplace
with a mechanism of lodging complaints. Besides,
redressal is placed on the intranet for the benefit of
employees.

Following is a summary of sexual harassment
complaints received and disposed of during F.Y.
2025-2026.

No. of complaints not resolved as on 1st April, 2025:	Nil
No. of complaints received in financial year 2025-26:	Nil
No. of complaints resolved in financial year 2025-2026:	Nil
No. of complaints not resolved as on 31st March, 2026:	Nil

28. STATUTORY AUDITORS AND
INDEPENDENT AUDITORSRs.REPORT:

M/s. A Bafna & Associates., Chartered Accountants,
(Firm Registration No. 121901W) have been
appointed as the Statutory Auditor of your Company
for a tenure of 5 (five) years till the 14^th AGM to be
held in the Calendar Year 2027. The AuditorsRs.Report
given by M/s. A Bafna & Associates, Statutory Auditor,
on the Financial Statements of your Company, for
the year ended March 31, 2026, forms part of the
Annual Report.

Auditor Observation:

In Our Opinion and according to the information and
explanation given to us, the remuneration paid by
the Company to its directors during the current year
is in excess of the limit laid down under the section
197 of the Act.

Reply by Board of Directors:

The Board would like to clarify that the managerial
remuneration of Rs.22.62 Lacs paid to Mr. Hardik
Desai for the financial year 2025-26 were found
in excess of the maximum permissible limit as
prescribed under Section 197 of the Act from
the total managerial remuneration paid, but
the said remuneration was within the limits as
approved by the members at previous AGM held on
September 21, 2023.

Further the managerial remuneration of Rs.6.37 Lacs
paid to Mr. Ashish Anandsingh Bafna for the financial
year 2025-26 were found in excess of the maximum
permissible limit as prescribed under Section 197
of the Act from the total managerial remuneration
paid. For which suitable resolutions are included in
the AGM notice for the membersRs.approval.

Apart from this, there is no qualification, reservation
or adverse remark or any disclaimer in their Report.
The AuditorsRs.Report for the year is self-explanatory &
does not contain any modified opinion, hence need
no comments.

29. REPORTING OF FRAUDS:

There have been no frauds reported under sub-
section (12) of Section 143 of the Act, during the
financial year under review, to the Audit Committee
or the Board of Directors.

30. SECRETARIAL AUDITOR AND
SECRETARIAL AUDIT REPORT:

The Company has appointed M/s. Amareliya &
Associates, Practicing Company Secretary (ICSI M.
No. F12452, COP: 24321, PR: 4735/2023) as the
Secretarial Auditor for the financial year 2025-26 in
accordance with Section 204 of the Act. The Report
on Secretarial Audit for the Financial Year 2025-26,
in Form MR-3, is annexed hereto as Annexure-D and
forms part of this Report.

Auditor Observation:

There was only 2 (Two) members (non-executive-
independent Directors) in Nomination and
Remuneration Committee instead of minimum
3 (Three) members as per Section 178 of the
Companies Act, 2013 from November 22, 2025.

Reply by Board of Directors:

As on the date of resignation of Mrs. Maniya Desai,
Director and Member of the NRC Committee, the
Company did not have any Non-Executive Directors
in the board for appointment in the NRC Committee.
However, pursuant to the Regulations 15 (2) ofthe SEBI
(Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("LODR Regulations"), the
Company was not required to comply with the
Corporate Governance requirements prescribed
thereunder during the relevant period. Further, the
Company have appointed an Independent Directors
on 13 June 2026, and reconstituted the NRC with
the newly appointed Independent Director, in
compliance with the applicable requirements.

31. SECRETARIAL STANDARDS:

The Company has complied with all the applicable
secretarial standards issued by the Institute of
Company Secretaries of India.

32. INTERNAL AUDITORS:

Pursuant to the provisions of Section 138 of the
Companies Act, 2013, the Board of Directors of the
Company have appointed M/s. DAC & Co., Chartered
Accountant, having FRN No. 137035W as an
Internal Auditor of the Company on May 28, 2025
for the financial year 2025-26.

The audit committee of the Board of Directors in
consultation with the Internal Auditor formulates
the scope, functioning, periodicity and methodology
for conducting the internal audit.

33. COST RECORDS AND AUDIT:

The Company has not appointed the Cost Auditor
as pursuant to Section 148 of the Companies Act,
2013 read with the Companies (Cost Records and
Audit) Amendment Rules, 2014, the cost audit is not
applicable to the Company.

34. INTERNAL CONTROL SYSTEM:

Your Company has put in place adequate internal
financial controls with reference to the financial
statements. The Board has adopted the policies and
procedures for ensuring the orderly and efficient
conduct of its business including adherence to the
Companys policies, the safeguarding of its assets,
prevention and detection of frauds and errors,
accuracy and completeness of the accounting
records and timely preparation of reliable financial
disclosures. During the year, such controls were
tested and no reportable material weaknesses in
design or operation were observed. The Internal
Auditor certifies on the assurance of adequacy of
Internal Control System on quarterly basis which
are regularly reviewed by the Audit Committee.
Independence of the audit is ensured by the direct
reporting of internal audit functions to the Audit
Committee of the Board.

35. RISK MANAGEMENT:

Risk Management is the systematic process
of understanding, measuring, controlling and
communicating an organizations risk exposures
while achieving its objectives. Risk Management is an
important business aspect in the current economic
environment and its objective is to identify, monitor
and take mitigation measures on a timely basis in
respect of the events that may pose risks for the
business. The Companys risk-management strategy
is to identify, assess and mitigate any significant risks.
We have established processes and guidelines, along
with a strong overview and monitoring framework
at the Board and Senior Management levels. The
Board of Directors regularly reviews risks and threats
and takes suitable steps to safeguard its interest and
that there is no element of risk identified that may
threaten the existence of the Company. The focus
shifts from one area to another area depending
upon the prevailing situation. A detailed report on
significant risks and mitigation is forming part of
Managements Discussion and Analysis.

36. INSURANCE:

The Company has taken all the necessary steps
to insure its properties and insurable interests, as
deemed appropriate and also as required under the
various legislative enactments.

37. INVESTOR EDUCATION AND
PROTECTION FUND:

During the year under review, the Company has not
transferred any amount to the Investor Education
and Protection Fund.

38. LOAN FROM DIRECTORS:

During the year under reporting, the Company has
taken Rs.750.50 Lacs Unsecured Loan from directors
and relatives of directors and repaid Rs.764.61
Lacs. Pursuant to rule 2(c)(viii) of the Companies
(Acceptance of Deposits) Rules, 2014 declaration
has been received from them that the amount
has not been given out of the funds acquired by
them, either by borrowings or by accepting loans or
deposits from others. Refer Note No. 30 (B) of the
Financial Statement.

39. RELATED PARTY TRANSACTIONS:

All contracts, arrangements and transactions
entered by the Company with related parties during
the financial year 2025-26 were in the ordinary
course of business and on an arms length basis.

During the financial year under review, the Company
entered into contracts, arrangements, or transactions
that fall within the scope of Section 188(1) of the
Companies Act, 2013. The prescribed particulars of
such related party transactions, as required under
Form AOC-2, are annexed hereto as Annexure-E and
form an integral part of this Report.

Further, all such contracts/arrangements/
transactions were placed before the Audit Committee
and Board, for their approval. Prior approval/s of the
Audit Committee/Board are obtained on an annual
basis, which is reviewed and updated on quarterly
basis.

40. PARTICULARS RELATING TO
CONSERVATION OF ENERGY, TECHNOLOGY
ABSORPTION, FOREIGN EXCHANGE
EARNINGS AND OUTGO:

A statement giving details of conservation of energy,
technology absorption, foreign exchange earnings
and outgo, in accordance with Section 134(3)(m) of
the Act, read with the Rule 8(3) of the Companies
(Accounts) Rules, 2014, is annexed as "Annexure-G"
hereto and forms part of this report.

41. EQUAL EMPLOYMENT OPPORTUNITIES:

Being an equal opportunity employer, the company
will do its utmost to ensure that all of its employees are
treated fairly during the period of their employment
irrespective of their race, religion, sex (including
pregnancy), color, creed, age, national origin, physical
or mental disability, citizenship status, ancestry,
marital status veteran status, political affiliation,
or any other factor protected by law. All decisions
regarding employment will be taken based on merit
and business needs only.

42. ANNUAL RETURN:

In Compliance with the provision of Section 92(3)
and Section 134(3)(a) of the Companies Act,
2013, the draft Annual Return in Form MGT-7
for the Financial Year 2025-26, is made available
on the website of the Company at https://www.
tridentlifeline.com.

43. MATERIAL CHANGES AND
COMMITMENTS AFTER THE CLOSURE
OF THE FINANCIAL YEAR TILL THE DATE
OF THIS REPORT, WHICH AFFECTS THE
FINANCIAL POSITION OF THE COMPANY:

There is no Material changes and commitments
after the closure of the financial year till the date of
this Report, which affects the financial position of
the Company.

44. COMPLIANCE WITH THE MATERNITY
BENEFIT ACT, 1961:

The Company has complied with the provisions of the
Maternity Benefit Act, 1961, including all applicable
amendments and rules framed thereunder. The
Company is committed to ensuring a safe, inclusive,
and supportive workplace for women employees.
All eligible women employees are provided with
maternity benefits as prescribed under the Maternity
Benefit Act, 1961, including paid maternity leave,
nursing breaks, and protection from dismissal
during maternity leave.

The Company also ensures that no discrimination
is made in recruitment or service conditions on the
grounds of maternity. Necessary internal systems
and HR policies are in place to uphold the spirit and
letter of the legislation.

45. GENERAL:

Your Directors state that no disclosure or reporting
is required in respect of the following items as there
were no transactions on these items during the year
under review:

a. Issue of Equity Shares with differential rights as
to dividend, voting or otherwise.

b. Issue of Shares (including sweat equity shares) to
employees of the Company under any scheme.

c. No significant or material orders were passed
by the Regulators or Courts or Tribunals which
impact the going concern status and Companys
operations in future.

d. There was no proceeding initiated/pending
against your Company under the Insolvency
and Bankruptcy Code, 2016.

e. The Company has not made any one-time
settlement for loans taken from the Banks or
Financial Institutions, and hence the details of
difference between amount of the valuation
done at the time of one-time settlement and
the valuation done while taking loan from the
Banks or Financial Institutions along with the
reasons thereof is not applicable.

46. ACKNOWLEDGEMENTS:

The Directors thank the Companys customers,
vendors, investors, lenders, bankers, Government
and Regulatory Authorities and Stock Exchange and
all other stakeholders for their continuous support.

The Directors also thank the Government of India,
Governments of various states in India, Governments
of various countries and concerned Government
departments and agencies for their co-operation.

The Directors appreciate and value the contribution
made by all our employees and their families and
the contribution made by every other member of
the Trident Lifelines family, for making the Company
what it is.